Task force #4 - Adherence issues and behavior changes: Achieving a long-term solution

Journal of the American College of Cardiology

Volumn 40, Issue 4, 2002, Pages 630-640

  Ockene, Ira S ^a   Hayman, Laura L ^a   Pasternak, Richard C ^a   Schron, Eleanor ^a   Dunbar Jacob, Jacqueline ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FAT INTAKE; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING CESSATION;

CARDIOVASCULAR DISEASES; HEALTH BEHAVIOR; HUMANS; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; RISK FACTORS;

EID: 0037151601     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02078-8     Document Type: Conference Paper

References (102)

1. Prescription medicine compliance: A review of the baseline of knowledge. A report of the National Council on Patient Information and Education
2. Health beliefs, personality, and adherence in hemodialysis patients: An interactional perspective
3. Predictors of patient adherence: Patient characteristics
4. Adherence to diet and drug regimens
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
6. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
7. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
8. Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study)
9. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention?
10. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
11. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines
12. Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass grafting
13. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada
14. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals
15. Interventions for helping patients to follow prescriptions for medications
16. Strategies to increase adherence to treatment
17. Physician-based smoking intervention: A rededication to a five-step strategy to smoking research
18. Neuropsychological functioning among cardiac rehabilitation patients
19. The adverse effects of antihypertensive therapy: The perception of patients
20. Side effect profile and adherence in the treatment of multiple sclerosis with interferon beta-1a
21. Compliance with treatment regimens in chronic asymptomatic diseases
22. Enhancing patient outcomes: Treatment adherence
23. Patient attitudes to commonly promoted medical interventions
24. Effects of early postmyocardial infarction exercise testing on self-perception and subsequent physical activity
25. Relationship of self-efficacy to cholesterol lowering and dietary change in hyperlipidemia
26. Perceived treatment efficacy: Assessment in rheumatoid arthritis
27. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction
28. Physicians' characteristics influence patients' adherence to medical treatment: Results from the Medical Outcomes Study
29. Relation of hostility to medication adherence, symptom complaints, and blood pressure reduction in a clinical field trial of antihypertensive medication
30. Impact of patient perceptions on compliance with treatment for hypertension
31. Multiple drug regimens: Medication compliance among veterans 65 years and older
32. Exercise adherence or maintenance among older adults: 1-Year follow-up study
33. Cognitive strategies and personality variables in adherence to exercise
34. Updating Norman's "Adequate Taxonomy:" Intelligence and personality dimensions in natural language and in questionnaires
35. Validation of the five-factor model of personality across instruments and observers
36. Patient non-compliance: Deviance or reasoned decision-making?
37. Understanding patients' decisions. Cognitive and emotional perspectives
38. Measuring adherence with medication regimens in clinical care and research
39. Adherence in the elderly
40. Factors associated with medication noncompliance in rural elderly hypertensive patients
41. The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking
42. Lifestyle management for patients with coronary heart disease
43. Increasing compliance
44. Can poor adherence be improved?
45. Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH)
46. Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: Does it work?
47. Helping patients to reduce their risk for coronary heart disease: An overview
48. Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence
49. Emotional support as a moderator of adjustment and compliance after coronary artery bypass surgery: A longitudinal study
50. Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study
51. Implementing preventive services. Success and failure in an outpatient trial
52. Increasing the efficacy of physician-delivered smoking interventions: A randomized clinical trial
53. Time for organizational development in healthcare organizations. Improving quality for patients means changing the organization
54. Stages and processes of self-change of smoking: Toward an integrative model of change
55. Health belief model and personal health behavior
56. Cultivating competence, self-efficacy, and intrinsic interest through proximal self-motivation
57. Determinants of relapse: Implications for the maintenance of behavior change
58. The social ecology of health: Leverage points and linkages
59. An ecological perspective on health promotion programs
60. TranstheoreticaI therapy: Toward a more integrative model of change
61. Transtheoretical model: Examining adolescent exercise behavior
62. An evaluation of Choose to Move 1999: An American Heart Association physical activity program for women
63. Characteristics of exercise behavior among college students: Application of social cognitive theory to predicting stage of change
64. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: Seven-year results of the Dietary Intervention Study in Children (DISC)
65. How individuals, environments and health behaviors interact
66. Outcomes of a field trial to improve children's dietary patterns and physical activity
67. Influencing personal and environmental conditions for community health: A multilevel intervention model
68. Compliance with cardiovascular disease prevention strategies: A review of the research
69. Smoking cessation and severity of disease: The Coronary Artery Smoking Intervention Study
70. Smoking intervention for cardiac patients: In search of more effective strategies
71. The social ecology of health promotion: Implications for research and practice
72. Behavioral and social science contributions to the health of adults in the United States
73. The long-run growth in obesity as a function of technological change
74. Adherence to antihypertensive therapy
75. Effect of physician-delivered nutrition training and a structured office environment on diet and serum lipid measurements
76. A controlled trial to integrate smoking cessation advice into primary care practice: Doctors helping smokers, round III
77. Preventive medicine 2000: Changing contexts and opportunities
78. Can lifestyle changes reverse coronary heart disease?
79. Telephone counseling improves adherence to colposcopy among lower-income minority women
80. A case-management system for coronary risk factor modification after acute myocardial infarction
81. Effects of a brief office-based intervention to facilitate diabetes dietary self-management
82. Public health approaches to cigarette smoking cessation
83. Self-help quit smoking interventions: Effects of self-help materials, social support instructions, and telephone counseling
84. Brief supportive telephone outreach as a recruitment and intervention strategy for smoking cessation
85. Telephone counseling for smoking cessation: Rationales and meta-analytic review of evidence
86. Implementation and acceptance of outreach telephone counseling for smoking cessation with nonvolunteer smokers
87. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions
88. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
89. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
90. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
91. Strategies for improving maintenance of weight loss. Toward a continuous care model of obesity management
92. Evidence for success of behavior modification in weight loss and control
93. Strategies to enhance compliance to weight-loss treatment
94. Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance
95. PACE+: Interactive communication technology for behavior change in clinical settings
96. Making cardiovascular disease prevention a reality
97. Conquering cardiovascular disease: Progress and promise